The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
BACKGROUND: There are limited data on factors predicting response to azathioprine and uncertainty regarding the optimal duration of treatment. PATIENTS AND METHODS: The notes of patients attending the Oxford IBD clinic from 1968 to 1999 were reviewed. Remission was defined as no need for oral stero...
Main Authors: | Fraser, A, Orchard, T, Jewell, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
by: Fraser, A, et al.
Published: (2002) -
CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE
by: Connell, W, et al.
Published: (1994) -
Peripheral arthropathies in inflammatory bowel disease - Reply
by: Orchard, T, et al.
Published: (1999) -
Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.
by: Campbell, A, et al.
Published: (1976) -
The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.
by: Fraser, A, et al.
Published: (2002)